| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/11/2002 | EP1263437A2 Farnesyl protein transferase inhibitor combinations with vinca alkaloids |
| 12/11/2002 | EP1263436A1 Use of glucosylceramide synthesis inhibitors in brain cancertherapy |
| 12/11/2002 | EP1263435A1 Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis |
| 12/11/2002 | EP1263434A1 Compounds with 5-ht 2 and 5-ht 1a agonist activity for treating glaucoma |
| 12/11/2002 | EP1263433A2 Glycogen phosphorylase inhibitor |
| 12/11/2002 | EP1263432A1 Use of compatible solutes as inhibitors of the enzymatic decomposition of macromolecular biopolymers |
| 12/11/2002 | EP1263431A1 Condensation derivatives of thiocolchicine and baccatin as antitumor agents |
| 12/11/2002 | EP1263430A2 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases |
| 12/11/2002 | EP1263429A1 Antiviral therapy |
| 12/11/2002 | EP1263428A2 Free radical scavengers for the treatment of premature birth |
| 12/11/2002 | EP1263427A1 Il-8 receptor antagonists |
| 12/11/2002 | EP1263426A1 Preparations for the non-traumatic excision of a nail |
| 12/11/2002 | EP1263425A1 Use of comt inhibitors as analgesics |
| 12/11/2002 | EP1263424A2 Use of deramciclane for the treatment of anxiety and depression |
| 12/11/2002 | EP1263423A2 Composition for the prevention and/or treatment of vascular diseases, comprising propionyl l-carnitine and coenzyme q10 |
| 12/11/2002 | EP1263422A1 Agent for treating illnesses of the tracheobronchial tract, especially chronic obstructive pulmonary disease (copd) |
| 12/11/2002 | EP1263421A2 Dual inhibitors of cholesteryl ester and wax ester synthesis for sebaceous gland disorders |
| 12/11/2002 | EP1263420A2 Retinoid formulations for aerosolization and inhalation |
| 12/11/2002 | EP1263419A2 Compounds capable of binding with the cytoskeleton |
| 12/11/2002 | EP1263418A2 Cartilage enhancing food supplements and methods of preparing the same |
| 12/11/2002 | EP1263414A1 Pharmaceutical compositions of glycogen phosphorylase inhibitors |
| 12/11/2002 | EP1263413A1 Method of preparing solid dispersions |
| 12/11/2002 | EP1263411A2 Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa |
| 12/11/2002 | EP1263409A1 Orally administered controlled delivery system for once daily administration of ciprofloxacin |
| 12/11/2002 | EP1263401A1 Oral composition comprising 2'-hydroxypropiophenone |
| 12/11/2002 | EP1263394A2 The use of plant extracts and sugars to protect keratinous tissue |
| 12/11/2002 | EP1263300A1 Improvements in or relating to solubilisation of flavonols |
| 12/11/2002 | EP1263297A1 Diabetic nutritionals |
| 12/11/2002 | EP1175149B1 Disinfecting composition based on h2o2, acids and metal ions |
| 12/11/2002 | EP1163258B1 22r-hydroxycholesta-8,14-diene derivatives for the inhibition of meiosis |
| 12/11/2002 | EP1149104B1 Pyrrolobenzodiazepine carboxyamide vasopressin agonists |
| 12/11/2002 | EP1100805B1 Medicine nitrate salts |
| 12/11/2002 | EP1095025B1 Benzimidazoles, production thereof and use thereof as medicaments |
| 12/11/2002 | EP1077683B1 Antidepressant therapy |
| 12/11/2002 | EP1071433B1 2',2'-difluoronucleosides for immunosuppressive therapy and combined pharmaceutical compositions |
| 12/11/2002 | EP1063969B1 Topical formulation of oil-in-water type as a carrier for providing a reduced irritant effect |
| 12/11/2002 | EP1056716B1 Cyclohexanediole derivatives |
| 12/11/2002 | EP1032572B1 Pyranones, method for the production and use thereof |
| 12/11/2002 | EP1023072B1 Analgesic compositions comprising a cholecystokinin and an opioid |
| 12/11/2002 | EP1017378B1 Amide derivatives for the treatment of diseases mediated by cytokines |
| 12/11/2002 | EP0984943B1 Azacyclooctane and heptane derivatives, their preparation and usein therapy |
| 12/11/2002 | EP0981521B1 Novel macrocyclic compounds as metalloprotease inhibitors |
| 12/11/2002 | EP0966436B1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
| 12/11/2002 | EP0956009B9 Treatment of neurodegenerative conditions with nimesulide |
| 12/11/2002 | EP0942741B1 Lectin compositions and uses thereof |
| 12/11/2002 | EP0937064B1 Substituted oximes derivatives useful as neurokinin antagonists |
| 12/11/2002 | EP0937062B1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| 12/11/2002 | EP0937060B1 Cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| 12/11/2002 | EP0934257B1 Substituted n-arylmethylamino derivatives of cyclobutene-3,4-diones |
| 12/11/2002 | EP0925294B1 Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and method of reducing tnf-alpha levels |
| 12/11/2002 | EP0923568B1 Novel benzofuran-4-carboxamides |
| 12/11/2002 | EP0912110B1 Improvements in or relating to compositions containing creatine |
| 12/11/2002 | EP0907632B1 Inhibition of matrix metalloproteases by substituted phenethyl compounds |
| 12/11/2002 | EP0906754B1 Rapid-release s1452 tablets |
| 12/11/2002 | EP0904339B9 Sterol extraction with a polar solvent to give low sterol microbial oil |
| 12/11/2002 | EP0894001B1 Inhibitor of immunoglobulin e antibody production for the treatment of type i allergy-related diseases |
| 12/11/2002 | EP0873337B1 Salts of n-(4-oxo-2-(1h-tetrazoyl-5-yl)-4h-1-benzopyran-8-yl)-4-(4-phenylbutoxy)benzamide |
| 12/11/2002 | EP0863891B1 (methylsulfonyl)phenyl-2-(5h)-furanones as cox-2 inhibitors |
| 12/11/2002 | EP0859630B1 Combination of temozolomide and alpha-ifn for the treatment of advanced cancer |
| 12/11/2002 | EP0837854B1 Alkyl amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| 12/11/2002 | EP0831871B1 Relaxin-like factor and methods and uses thereof |
| 12/11/2002 | EP0820289B1 Trapidil for use in the treatment of immuno-modulatorily influencible cases |
| 12/11/2002 | EP0807185B9 Antitumor preparations containing a lipoteichoic acid from steptococcus |
| 12/11/2002 | EP0805796B1 Cell adhesion inhibitors |
| 12/11/2002 | EP0793498B1 Bicyclic heterocyclic compounds for the treatment of impotence |
| 12/11/2002 | EP0788511B1 Cyclic hexapeptides having antibiotic activity |
| 12/11/2002 | EP0782567B2 Isothiourea derivatives as no synthase inhibitors |
| 12/11/2002 | EP0754052B1 Antiviral wound healing composition containing a pyruvate, an antioxidant, a mixture of fatty acids and an antiviral compound |
| 12/11/2002 | EP0752813B1 Inhibitors of metazoan parasite proteases |
| 12/11/2002 | EP0750909B1 The use of amino hydrogenated quinazoline compounds and derivatives thereof for abstaining from drug dependence |
| 12/11/2002 | EP0723447B1 Use of (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 12/11/2002 | EP0722446B1 Distamycin a analogues as antitumour or antiviral agents |
| 12/11/2002 | EP0721455B1 Tetrahydropyridine-(or 4-hydroxypiperidine)alkylazoles having an affinity for sigma and/or 5ht1a receptors |
| 12/11/2002 | EP0662958B1 1-(2-oxo-acetyl)-piperidine-2-carboxylic acid derivatives as multi-drug-resistent cancer cell sensitizers |
| 12/11/2002 | EP0628030B1 2,3,4,5-TETRAHYDRO-1H --3-BENZAZEPINES HAVING ANTI-PSYCHOTIC ACTIVITY, AND SYNTHESIS OF $g(a)-SUBSTITUTED-ARYLACETAMIDES |
| 12/11/2002 | CN1385036A Communications system |
| 12/11/2002 | CN1384838A Macrolide antinfective agents |
| 12/11/2002 | CN1384835A Tricycle inhibitors of poly(ADP-ribose) polymerases |
| 12/11/2002 | CN1384834A Pyrrolo [2,3-d] pyrimidine nucleoside analoys |
| 12/11/2002 | CN1384833A Synthesis and methods of use of 9-substituted guanine derivatives |
| 12/11/2002 | CN1384832A Pesticidal aminoheterocyclamide compounds |
| 12/11/2002 | CN1384831A Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| 12/11/2002 | CN1384830A Novel spiroheterocyclic compoundsus reversible inhibitors of cysteine proteases |
| 12/11/2002 | CN1384829A Sodium-hydrogen exchanger type 1 inhibitor crystals |
| 12/11/2002 | CN1384827A Indeno-, naphtho-, and benzocyclohepta-dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments |
| 12/11/2002 | CN1384826A Pesticidal N-heteroaryl alpha-alkoximino-carboxamides |
| 12/11/2002 | CN1384825A Benzylidene thiazolidiones and analogues and their use in treatment of inflammation |
| 12/11/2002 | CN1384822A Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-[2-(3,4-dimethoxyphenyl)ethoxy]-3,3-diphenylpropionate and use thereof endothelin antagonist |
| 12/11/2002 | CN1384821A Method for improving solubility of tricyclic amino alcohol derivatives |
| 12/11/2002 | CN1384817A Polymorphic N-[3-[[2-(3,4-dimethyoxyphenyl)ethyl]amino]propyl]-4-nitro benzamide hydrochloride |
| 12/11/2002 | CN1384816A Polymorphic forms of sertraline hydrochloride |
| 12/11/2002 | CN1384814A Phenoxy carboxylic acid compounds and compositions for delivering active agents |
| 12/11/2002 | CN1384756A Pharmaceutical formulations and use thereof in prevention of stroke, diabetes and/or congestive heart failure |
| 12/11/2002 | CN1384754A Method and composition for treating prostate cancer |
| 12/11/2002 | CN1384750A Plant extract mixtures and their uses |
| 12/11/2002 | CN1384749A Use of diphophonic acid in treatment of vasculogenesis |
| 12/11/2002 | CN1384748A Mesoprogestins (progesterone receptor modulators) as component of female contraceptives |
| 12/11/2002 | CN1384747A Use of 2-amino-3,4-dihydro-quinazolines for producing medicament for treating or preventing diseases caused by ischaemic conditions |
| 12/11/2002 | CN1384746A 单位剂量形式 Unit dosage forms |
| 12/11/2002 | CN1384745A Pharmaceutical compositions containing fluoroquinolone antibiotic drug and xanthan gum |